Gene79366
HMGN5: high mobility group nucleosome binding domain 5
Cite this record
ConductScience Library. HMGN5: high mobility group nucleosome binding domain 5. Genes, record 79366. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/79366
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P82970 | High mobility group nucleosome-binding domain-containing protein 5 | 282 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents49
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20250084141 A1 | 2025-03-13 | 5056 | P82970 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 5056 | P82970 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 21435 | P82970 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 219961 | P82970 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 38335 | P82970 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38335 | P82970 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38335 | P82970 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 141306 | P82970 | Espacenet |
| US 20220025369 A1 | 2022-01-27 | 5056 | P82970 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 5056 | P82970 | Espacenet |
NIH grants181
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HMGN5 papers | Newest fiscal year |
|---|---|---|---|
| R35GM118060 | Mechanisms of Eukaryotic Gene Regulation | 2 | 2025 |
| R35GM145296 | Mechanism of cytoskeletal transport and transcription-coupled DNA repair | 2 | 2025 |
| P01CA265794 | Genome Instability Induced Anti-Tumor Immune Responses | 1 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 1 | 2025 |
| P30CA013148 | Comprehensive Cancer Center Support Grant | 1 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 1 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 1 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 1 | 2025 |
| P30CA093373 | Cancer Center Support Grant P30 | 1 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 1 | 2025 |
Source NIH's project files
Papers297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating Single-Cell and RNA Sequencing to Predict Glioma Prognosis Through Lactylation. | Int J Mol Sci | 2026 | 41751785 | PubTator, text mining | PubMed |
| HMGN2 induces pyroptosis in tumour cells by modulating the STT3B/PD‑L1/caspase‑1/GSDMD axis. | Mol Med Rep | 2026 | 41574665 | PubTator, text mining | PubMed |
| The MYC-dependent lncRNA MB3 inhibits apoptosis in Group 3 Medulloblastoma by regulating the TGF-β pathway via HMGN5. | Cell Death Dis | 2025 | 41198629 | PubTator, text mining | PubMed |
| A new serological autoantibody signature associated with multiple sclerosis. | Neurobiol Dis | 2025 | 41038542 | PubTator, text mining | PubMed |
| Structural basis of nucleosome recognition by the conserved Dsup and HMGN nucleosome-binding motif. | Genes Dev | 2025 | 40721296 | PubTator, text mining | PubMed |
| Early dynamics of chromatin decompaction drive nuclear stiffening. | Proc Natl Acad Sci U S A | 2025 | 40456001 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1. | Ann Rheum Dis | 2025 | 40348637 | PubTator, text mining | PubMed |
| A pH-Responsive Dendritic-DNA-Based Nanohydrogel for Dual Drug Delivery. | Biomolecules | 2025 | 40305283 | PubTator, text mining | PubMed |
| Proteomic analysis of plasma exosomes in patients with metastatic colorectal cancer. | Clin Proteomics | 2024 | 39385083 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79366
GET https://conductscience.org/api/genes/v1/79366/patents?page=2